# Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions

> **NCT01532570** · PHASE3 · COMPLETED · sponsor: **Tanabe Pharma Corporation** · enrollment: 18 (actual)

## Conditions studied

- Behcet's Disease
- Behcet Syndrome
- Neuro-Behcet's Disease

## Interventions

- **DRUG:** TA-650

## Key facts

- **NCT ID:** NCT01532570
- **Lead sponsor:** Tanabe Pharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01532570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01532570, "Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01532570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*